BCYC vs BFRI

Bicycle Therapeutics plc vs Biofrontera Inc. — Valuation Comparison 2026

BCYC

Pharmaceutical Preparations
Bicycle Therapeutics plc
Quality
6.1
out of 10
Value Trap
24
SAFE
Price
$4.69
Last close
Models
9/13
Active
VS

BFRI

Pharmaceutical Preparations
Biofrontera Inc.
Quality
5.6
out of 10
Value Trap
30
LOW
Price
$0.89
Last close
Models
7/13
Active

Model-by-Model Comparison

ModelType BCYC Fair ValueBCYC Upside BFRI Fair ValueBFRI Upside
Bayesian DCF Intrinsic $5.46 +16.4% $0.37 -58.0%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $•••.•• ••.•% $•••.•• ••.•%
Dynamic NAV Asset-Based $9.86 +110.3% $1.72 +93.9%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $•••.•• ••.•% $•••.•• ••.•%
RCMH-DCF Intrinsic $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for BCYC vs BFRI — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

BCYC vs BFRI — Which Stock Is More Undervalued?

BCYC scores higher with a 6.1/10 quality rating vs BFRI's 5.6/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Bicycle Therapeutics plc (BCYC) and Biofrontera Inc. (BFRI) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

BCYC currently trades at $4.69 with a QOC of 6.1/10, while BFRI trades at $0.89 with a QOC of 5.6/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).